LifeArc
Template:Short description Template:DMCA
Page Module:Infobox/styles.css has no content.Page Template:Infobox company/styles.css has no content.
| Lua error in package.lua at line 80: module 'Module:InfoboxImage/data' not found. | |
Company type | Charity Commission for England and Wales |
|---|---|
| ISIN | Script error: No such module "WikidataIB". |
| Industry | Script error: No such module "WikidataIB". |
| Predecessor | Script error: No such module "WikidataIB". |
| Incorporated | Script error: No such module "WikidataIB". |
| Founded | Script error: No such module "WikidataIB". |
| Founder | Script error: No such module "WikidataIB". |
| Defunct | Script error: No such module "WikidataIB". |
| Fate | Renamed LifeArc in 2017 |
| Successor | Script error: No such module "WikidataIB". |
| Headquarters | , |
Number of locations | London, Stevenage, Edinburgh |
Key people | Dr Ian Gilham (Chairman Dr Sam Barrell (CEO)[1] |
| Services | IP management, drug discovery, diagnostics development, antibody engineering, charity portfolio review |
| Revenue | Script error: No such module "WikidataIB". |
| Script error: No such module "WikidataIB". | |
| Script error: No such module "WikidataIB". | |
| Total assets | Script error: No such module "WikidataIB". |
Number of employees | Script error: No such module "WikidataIB". |
| Parent | Script error: No such module "WikidataIB". |
| Website | lifearc |
Script error: No such module "Check for conflicting parameters".Script error: No such module "Check for deprecated parameters".
LifeArc is a British life science medical research charity.[2] It was established in 2000 as MRC Technology to translate the work of UK Medical Research Council (MRC) research scientists.[3]
Today, LifeArc provides intellectual property identification, protection and commercialisation, technology development, diagnostic development, early stage drug discovery and antibody humanization services for academic, biotechnological and pharmaceutical organisations. Profits from LifeArc's activities are reinvested into further research.
History
The organisation was set up as a charity and a company limited by guarantee in 2000 to incorporate patenting, licensing and research functions.[4]
LifeArc humanised a number of antibodies on behalf of other organisations. Four of these, Tysabri (Biogen Idec/Elan), Actemra (Hoffmann-La Roche/Chugai), Entyvio (Millenium Pharma/Takeda) and Keytruda (Merck/MSD), are licensed drugs.[5][failed verification]
In 2010, LifeArc signed a deal with the drug company AstraZeneca to share chemical compounds to help identify potential treatments for serious diseases.[6][7]
LifeArc is a member of a Global Drug Discovery Alliance along with the Centre for Drug Research and Development, the Scripps Research Institute, Cancer Research Technology, the Lead Discovery Centre and the Centre for Drug Design and Discovery.[8] Through its earnings from licensing agreements, LifeArc provides funding for academic research and early-stage medical research.[9]
In March 2019, LifeArc joined with Cancer Research UK and Ono Pharma to progress new immunotherapy drug targets for cancer.[10]
In May 2019, LifeArc announced it had sold part of its royalty rights for Keytruda to a subsidiary of Canada Pension Plan Investment Board (CPPIB) for US$1.297 billion, making it one of the biggest UK medical charities by size of investment.[11]
The charity claims that it has found a new approach for treating Alzheimer's disease in research carried out with the Universities of Leicester and Göttingen.[12]
LifeArc is based in Tavistock Square in Bloomsbury. As of 2025, it intends to occupy a large Edwardian building at 105-121 Judd Street, London WC1H 9NE, close to the Francis Crick Institute. The building was originally occupied by the Salvation Army and was latterly the headquarters of the Royal National Institute for the Blind. The interior has been demolished and will be rebuilt as offices and laboratories.[13]
References
Page Template:Reflist/styles.css has no content.
- ^ Page Module:Citation/CS1/styles.css has no content."Dr Sam Barrell CBE appointed as CEO of LifeArc". LifeArc.
- ^ Page Module:Citation/CS1/styles.css has no content."LifeArc, registered charity no. 1015243". Charity Commission for England and Wales.
- ^ Paul Feldman, Corinna Lotz, A world to win: a rough guide to a future without global capitalism, 2004, Lupus Books, Template:ISBN, 9780952345411
- ^ Page Module:Citation/CS1/styles.css has no content.Sir David Cooksey (12 January 2006). "A Review of UK Health Funding" (PDF). The Stationery Office. p. 20.
- ^ Page Module:Citation/CS1/styles.css has no content."Therapeutic Antibodies and the LMB". MRC Laboratory of Molecular Biology. Archived from the original on 22 March 2010. Retrieved 17 February 2012.
- ^ Mark Wigglesworth, Terry Wood, eds, Management of Chemical and Biological Samples for Screening Applications, 2012, John Wiley & Sons, Template:ISBN, 9783527645275, google books
- ^ Page Module:Citation/CS1/styles.css has no content."AstraZeneca and MRC Technology Form Strategic Alliance in Discovery Research, Utilising Shared Compound Libraries". AstraZeneca. 5 July 2010. Retrieved 3 January 2013.
- ^ Page Module:Citation/CS1/styles.css has no content.Edelson, Steve (2013). "Translational Globetrotting". SciBX: Science-Business EXchange. 6 (4): 78. doi:10.1038/scibx.2013.78.
- ^ Page Module:Citation/CS1/styles.css has no content."Stevenage BioScience Catalyst | LifeArc set to transform medical research landscape |". www.stevenagecatalyst.com. Retrieved 30 March 2019.
- ^ Page Module:Citation/CS1/styles.css has no content."Cancer Research UK, LifeArc and Ono Pharma form cancer therapy alliance". Hospital Healthcare Europe. 28 March 2019. Retrieved 30 March 2019.
- ^ Page Module:Citation/CS1/styles.css has no content."LifeArc monetises Keytruda® royalty interests to fund further research and investment". LifeArc. 20 May 2019. Retrieved 12 July 2019.
- ^ Page Module:Citation/CS1/styles.css has no content."New Alzheimer's treatment hailed by researchers". BBC News. 19 November 2021. Retrieved 24 November 2021.
- ^ Page Module:Citation/CS1/styles.css has no content."London Borough of Camden planning application no. 2025/1684/P". Retrieved 13 May 2025.
External links
Lua error in package.lua at line 80: module 'Module:Authority control/config' not found.
